Lion Biotechnologies Inc Stock OTC Bulletin Board
Equities
LBIO
US53619R1023
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | 161M | Sales 2025 * | 413M | Capitalization | 3.27B |
---|---|---|---|---|---|
Net income 2024 * | -352M | Net income 2025 * | -245M | EV / Sales 2024 * | 19.4 x |
Net cash position 2024 * | 133M | Net cash position 2025 * | 251M | EV / Sales 2025 * | 7.31 x |
P/E ratio 2024 * |
-9.02
x | P/E ratio 2025 * |
-16.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.7% |
Latest transcript on Lion Biotechnologies Inc
Managers | Title | Age | Since |
---|---|---|---|
Frederick Vogt
CEO | Chief Executive Officer | 50 | 16-09-29 |
Director of Finance/CFO | 51 | 20-12-13 | |
Brian Shew
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Merrill McPeak
BRD | Director/Board Member | 88 | 11-07-19 |
Director/Board Member | 56 | 16-06-06 | |
Michael Weiser
BRD | Director/Board Member | 61 | 18-03-14 |
1st Jan change | Capi. | |
---|---|---|
-14.52% | 11.48B | |
-33.09% | 2.2B | |
-18.60% | 2.05B | |
-27.59% | 1.49B | |
+17.10% | 1.01B | |
-3.06% | 743M | |
-33.50% | 413M | |
-46.94% | 377M | |
+27.44% | 374M |
- Stock Market
- Equities
- IOVA Stock
- LBIO Stock